GlassScriptPhysician profile
Elizabeth Levine
NPI 1952747818
$2,196.62
in general payments reported to CMS, 2019-2025
15 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $110 · 2022: $372 · 2023: $552 · 2024: $829 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,701 · Education: $13.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,700.81 |
| Education | $13.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $434.15 | 2023-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $394.14 | 2021-2023 | Farxiga |
| Amgen INC. | $319.97 | 2021-2024 | Repatha |
| Angiodynamics, INC. | $197.83 | 2024 | Angiovac |
| Atricure, INC. | $165.30 | 2025 | Synergy Ablation System, Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $164.96 | 2023-2025 | Lifevest |
| Medtronic, INC. | $103.50 | 2022-2023 | |
| Pfizer INC. | $80.93 | 2021-2023 | |
| Cvrx, INC. | $73.87 | 2022-2025 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.61 | 2021-2023 | Jardiance |
| Novartis Pharmaceuticals Corporation | $65.24 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $55.83 | 2023-2024 | Camzyos, Eliquis |
| Haemonetics Corporation | $27.18 | 2024-2025 | Teg6s Hemostasis System |
| Kestra Medical Technology Services, INC. | $26.56 | 2025 | Assure Wcd |
| Astellas Pharma US INC | $17.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.